Mezzasalma Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $983K | Sell |
14,239
-1,855
| -12% | -$128K | 0.3% | 52 |
|
|
2025
Q1 | $1.12M | Sell |
16,094
-1,767
| -10% | -$123K | 0.39% | 46 |
|
|
2024
Q4 | $1.54M | Sell |
17,861
-6,146
| -26% | -$529K | 0.5% | 38 |
|
|
2024
Q3 | $2.86M | Buy |
24,007
+1,085
| +5% | +$129K | 1.13% | 27 |
|
|
2024
Q2 | $3.27M | Buy |
22,922
+11,022
| +93% | +$1.57M | 1.4% | 19 |
|
|
2024
Q1 | $1.53M | Buy |
+11,900
| New | +$1.53M | 0.72% | 30 |
|